Form 4: ELUTIA Director Brigid Makes Granted Over 60,000 Stock Options

ELUTIA INC. director Brigid Makes was granted 60,339 stock options with an exercise price of $1.65 as part of the company's non-employee director compensation program.

Summary

• Brigid Makes, a Director of ELUTIA INC. (ELUT), was granted 60,339 stock options.
• The options have an exercise price of $1.65 per share.
• The grant date for these options was May 29, 2025.
• The options expire on May 29, 2035.
• Vesting occurs on the earlier of the day immediately preceding the Issuer's first annual meeting following the grant date or the first anniversary of the grant date, contingent on continued service on the board.
• This grant was made automatically under the Issuer's Non-Employee Director Compensation Program.

Sentiment

Score: 7

Explanation: The filing reports a standard, positive event of aligning director incentives with shareholder value through equity compensation. It does not contain any negative or unexpected information.

Positives

• The grant of stock options to Director Brigid Makes aligns her interests with shareholders, incentivizing long-term performance.
• The automatic grant under a compensation program indicates a structured and transparent approach to director remuneration.

Negatives

• No specific negative points are identified in this Form 4 filing, as it primarily reports a routine compensation event.

Risks

• The value of the stock options is subject to the future performance of ELUTIA INC.'s stock price; if the stock price does not exceed the exercise price of $1.65, the options may not be in-the-money.
• Vesting is contingent on continued service, meaning the director must remain on the board to fully realize the benefit of the options.

Future Outlook

The filing itself does not provide a future outlook for the company, but the grant of options suggests an expectation of future value creation for the company's stock.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction, specifically a director's equity compensation. Such grants are common practice across industries to align director incentives with shareholder interests, particularly in growth-oriented companies like those often found in the biotech or technology sectors (implied by 'ELUTIA INC.').

Comparison to Industry Standards

• The grant of stock options to non-employee directors is a standard compensation practice across various industries, particularly in publicly traded companies.
• The specific number of options (60,339) and exercise price ($1.65) would need to be compared against similar-sized companies in the same industry (e.g., biotechnology, pharmaceuticals, or medical devices, depending on ELUTIA's specific business) and their non-employee director compensation programs to assess if it's within typical ranges. Without specific industry benchmarks or comparable company data, a detailed assessment is not possible from this document alone.

Corporate Governance

Stakeholder Impact

• Shareholders: The grant of stock options aims to align the director's interests with shareholders by incentivizing long-term stock price appreciation.
• Employees: No direct impact on employees is mentioned in this filing.
• Management: The compensation structure for directors is part of the overall corporate governance framework that management operates within.

Next Steps

• The options will vest based on the specified schedule, contingent on the director's continued service.
• The director may choose to exercise these options at or after vesting, prior to their expiration date, subject to company policy and insider trading regulations.

Key Dates

Keywords

ELUTIA INC., ELUT, Form 4, Stock Options, Director Compensation, Equity Grant, Insider Transaction, Brigid Makes